Companies / France
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Sanofi-Aventis Linked With Move For BMS
January 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
French drug giant Sanofi-Aventis is understood to be in talks with US pharmaceutical firm Bristol-Myers Squibb (BMS) over a possible merger, according to unnamed sources reported in the French press. BMS has been frequently linked with Sanofi-Aventis, which is over twice its size, and is already ithe US sales partner on two of the French group's leading drugs - blood thinner Plavix (clopidogrel bisulfate) and blood pressure drug Avapro (irbesartan). A successful deal would create the world's largest drugmaker, outstripping US-based Pfizer , with estimated global sales of US$56bn.